At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Apr 2, 2026 at 17:13 ET
Two C-suite executives at Edwards Lifesciences sold shares worth $459K in a 7-day window, with open-market sales following derivative exercises. The total value represents less than 0.001% of the company's $46.7B market cap, indicating routine, non-material insider activity.
- Two C-suite executives sold a combined $459K in shares over 7 days.
- Sales followed derivative exercises, a common tax-related transaction pattern.
- Total insider sales represent less than 0.001% of market cap, negligible in scale.
- No purchases or non-routine transactions observed.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access